Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Frederick Ruthardt
OpenAlex ID:
A5072284234
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection
2023
·
Matthew D. Sims
, Sahil Khanna
, et al.
·
JAMA Network Open
·
83
PDF
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI
2024
·
Colleen S. Kraft
, Matthew Sims
, et al.
·
Infectious Diseases and Therapy
·
9
PDF
Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI
2024
·
Colleen S. Kraft
, Matthew Sims
, et al.
·
Infectious Diseases and Therapy
PDF
Show more works
View as search
Works count:
3
Citation count:
92
H-index:
2
I10-index:
1
Year
Topic
Type
